Skip to content
Recall Observatory FDA recall evidence

Drug product

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534, NDC 68382-354-05

D-0149-2017

August 03, 2016

Class III

Product summary

Firm
Zydus Pharmaceuticals USA Inc
Event
Event 75696
Status
Terminated
Classification
Class III
Quantity
2,472 units
Official record key
drug-enforcement:D-0149-2017

Official wording

Reason: Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.

Code information: Lot #: MR3365, Exp. Feb 17

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Dissolution Specifications